<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Silent brain <z:mpath ids='MPATH_124'>infarcts</z:mpath> and white matter lesions are frequently seen on magnetic resonance imaging in healthy elderly people and both are associated with an increased risk of <z:hpo ids='HP_0001297'>stroke</z:hpo> and <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Plasma total <z:chebi fb="0" ids="17230">homocysteine</z:chebi> may be a potentially modifiable risk factor for <z:hpo ids='HP_0001297'>stroke</z:hpo> and <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>We examined whether elevated total <z:chebi fb="0" ids="17230">homocysteine</z:chebi> levels are associated with silent brain <z:mpath ids='MPATH_124'>infarcts</z:mpath> and white matter lesions </plain></SENT>
<SENT sid="3" pm="."><plain>The Rotterdam Scan Study is a population-based study of 1,077 people aged 60 to 90 years who had cerebral magnetic resonance imaging </plain></SENT>
<SENT sid="4" pm="."><plain>The cross-sectional relation of total <z:chebi fb="0" ids="17230">homocysteine</z:chebi> with silent <z:mpath ids='MPATH_124'>infarcts</z:mpath> and white matter lesions was analyzed with adjustment for <z:e sem="disease" ids="C0850624" disease_type="Disease or Syndrome" abbrv="">cardiovascular risk factors</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>The mean plasma total <z:chebi fb="0" ids="17230">homocysteine</z:chebi> level was 11.5 micromol/l (standard deviation 4.1) </plain></SENT>
<SENT sid="6" pm="."><plain>The risk of silent brain <z:mpath ids='MPATH_124'>infarcts</z:mpath> increased with increasing total <z:chebi fb="0" ids="17230">homocysteine</z:chebi> levels (odds ratio 1.24/standard deviation increase, 95% confidence interval 1.06-1.45) </plain></SENT>
<SENT sid="7" pm="."><plain>The severity of periventricular white matter lesions and extent of subcortical white matter lesions were also significantly associated with total <z:chebi fb="0" ids="17230">homocysteine</z:chebi> levels, even after excluding those with silent brain <z:mpath ids='MPATH_124'>infarcts</z:mpath> </plain></SENT>
<SENT sid="8" pm="."><plain>The overall risk of having either a silent brain <z:mpath ids='MPATH_124'>infarct</z:mpath> or severe white matter lesions was strongly associated with total <z:chebi fb="0" ids="17230">homocysteine</z:chebi> levels (odds ratio 1.35/standard deviation increase, 95% confidence interval 1.16-1.58) </plain></SENT>
<SENT sid="9" pm="."><plain>We concluded that total <z:chebi fb="0" ids="17230">homocysteine</z:chebi> levels are associated with silent brain <z:mpath ids='MPATH_124'>infarcts</z:mpath> and white matter lesions independent of each other and of other <z:e sem="disease" ids="C0850624" disease_type="Disease or Syndrome" abbrv="">cardiovascular risk factors</z:e> </plain></SENT>
</text></document>